Premium
Treatment Review: Non‐Steroid Anti‐Inflammatory Drugs in the Treatment and Long‐Term Prevention of Migraine Attacks
Author(s) -
Pradalier A.,
Clapin A.,
Dry J.
Publication year - 1988
Publication title -
headache: the journal of head and face pain
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.14
H-Index - 119
eISSN - 1526-4610
pISSN - 0017-8748
DOI - 10.1111/j.1526-4610.1988.hed2808550.x
Subject(s) - migraine , medicine , placebo , clinical trial , double blind , intensive care medicine , pharmacology , alternative medicine , pathology
SYNOPSIS After reviewing the pathophysiological features suggesting a role of prostaglandins in migraine, we have analyzed the literature concerning double‐blind trials of anti‐inflammatory drugs versus placebo or reference compounds in the acute and long‐term preventive treatment of migraine. For both of these indications, in the majority of double‐blind trials NSAID's have been found to be superior to placebo and equivalent to reference drugs. Certain points remain to be defined including, in particular, the following: • acceptability in the long‐term or by frequent repeated administrations, • efficacy according to different types or factors inducing migraine. More extensive trials are therefore indicated.